SCHEDULE 13G/A 0000935836-24-000694 0001105806 XXXXXXXX LIVE 2 Common Stock, par value $0.001 03/31/2025 0001858685 Biofrontera Inc. 09077D209 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 Rule 13d-1(c) LYTTON LAURENCE W X1 306700.00 0.00 306700.00 0.00 306700.00 N 3.5 IN The shares of Common Stock beneficially owned by the reporting person consist of 306,700 shares of Common Stock. The percentages reported in this Schedule 13G are based on 8,873,932 shares of Common Stock outstanding as of March 19, 2025, as reported in the Form 10-K filed by the Issuer on March 20, 2025. Biofrontera Inc. 120 Presidential Way, Suite 330, Woburn, MA 01801 Laurence W. Lytton 467 Central Park West New York, NY 10025 USA Y 306,700 3.5% 306,700 0 306,700 0 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. LYTTON LAURENCE W /s/ Laurence W. Lytton 05/15/2025